And some E‐CRC with oncogenic mutations for the Wnt, cell‐cycling pathway may progress to AD‐CRC by acquiring oncogenic mutations for the MAPK signaling pathway (especially KRAS). The gene discussed is KRAS; the disease is Alzheimer disease.